We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+8.89%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$17.5B
AUM Growth
+$597M
Cap. Flow
-$584M
Cap. Flow %
-3.34%
Top 10 Hldgs %
21.81%
Holding
132
New
7
Increased
47
Reduced
71
Closed
6

Top Sells

Rank Stock Value
1
NTNX icon
Nutanix
NTNX
+$240M
2
ZS icon
Zscaler
ZS
+$157M
3
NTRS icon
Northern Trust
NTRS
+$142M
4
P
Everpure Inc
P
+$106M
5
WDAY icon
Workday
WDAY
+$94.3M

Sector Composition

Rank Sector Weight
1 Technology 25.52%
2 Healthcare 22.57%
3 Industrials 15.37%
4 Financials 14.46%
5 Consumer Staples 13.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
P
1
Everpure Inc
P
$23.3B
$597M 3.42%
11,490,853
-2,367,110
-17% -$106M
FRPT icon
2
Freshpet
FRPT
$3.05B
$430M 2.46%
3,709,879
-84,180
-2% -$8.14M
FTV icon
3
Fortive
FTV
$18.2B
$428M 2.45%
6,598,277
-174,659
-3% -$10.6M
OKTA icon
4
Okta
OKTA
$23.6B
$408M 2.33%
3,896,922
-102,685
-3% -$9.47M
AME icon
5
Ametek
AME
$53.9B
$384M 2.2%
2,098,080
-336,325
-14% -$57.9M
EG icon
6
Everest Group
EG
$15.7B
$360M 2.06%
906,100
+45,705
+5% +$17.1M
CFR icon
7
Cullen/Frost Bankers
CFR
$10.5B
$359M 2.06%
3,192,486
+495,215
+18% +$52.9M
DXCM icon
8
DexCom
DXCM
$29.1B
$285M 1.63%
2,056,153
-53,830
-3% -$6.77M
EW icon
9
Edwards Lifesciences
EW
$49.1B
$283M 1.62%
2,964,168
+88,205
+3% +$7.41M
RYAN icon
10
Ryan Specialty Holdings
RYAN
$6.03B
$274M 1.57%
4,937,332
+1,079,505
+28% +$51.6M
WAT icon
11
Waters Corp
WAT
$37.4B
$264M 1.51%
765,654
-19,475
-2% -$6.4M
NTNX icon
12
Nutanix
NTNX
$16.1B
$260M 1.49%
4,210,711
-4,169,810
-50% -$240M
ROK icon
13
Rockwell Automation
ROK
$50.5B
$250M 1.43%
859,717
+388,400
+82% +$112M
TTC icon
14
Toro Company
TTC
$8.88B
$250M 1.43%
2,725,651
+280,855
+11% +$25.9M
TOST icon
15
Toast
TOST
$19B
$249M 1.42%
9,976,356
+833,390
+9% +$17.3M
MKC icon
16
McCormick & Company Non-Voting
MKC
$14.2B
$247M 1.41%
3,211,122
+136,080
+4% +$9.25M
PEN icon
17
Penumbra
PEN
$12.6B
$242M 1.39%
1,084,595
+616,700
+132% +$152M
CLX icon
18
Clorox
CLX
$12.1B
$240M 1.37%
1,567,839
-33,075
-2% -$4.94M
VEEV icon
19
Veeva Systems
VEEV
$33.8B
$237M 1.36%
1,022,902
-221,780
-18% -$47.9M
NDSN icon
20
Nordson
NDSN
$16.5B
$235M 1.35%
857,520
-155,010
-15% -$40.4M
BBWI icon
21
Bath & Body Works
BBWI
$3.96B
$234M 1.34%
4,683,155
-130,135
-3% -$5.84M
STE icon
22
Steris
STE
$22.8B
$233M 1.33%
1,035,461
-27,130
-3% -$6.12M
XYL icon
23
Xylem
XYL
$28.6B
$224M 1.28%
1,731,785
-556,676
-24% -$67.3M
PLNT icon
24
Planet Fitness
PLNT
$4.44B
$215M 1.23%
3,434,295
-71,130
-2% -$4.76M
KEYS icon
25
Keysight
KEYS
$50.6B
$205M 1.17%
1,310,900
-30,275
-2% -$4.66M

Similar funds

Champlain Investment Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Champlain Investment Partners held 132 positions worth $17.5B, up 3.5% from $16.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Champlain Investment Partners withdrew a net $584M in Q1 2024, closing 6 positions and reducing 71 holdings. Its most notable exit was Northern Trust, an estimated $142M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Champlain Investment Partners opened a new position in Confluent worth $145M.

  • Champlain Investment Partners's largest Q1 2024 buy was Confluent: 4,736,650 shares worth $145M.
  • Champlain Investment Partners added most to Penumbra in Q1 2024, an estimated $152M increase.
  • Champlain Investment Partners's biggest Q1 2024 reduction was Nutanix, cutting an estimated $240M.
  • Champlain Investment Partners fully exited Northern Trust in Q1 2024, selling an estimated $142M.
  • Champlain Investment Partners's ten largest holdings make up 22% of its $17.5B portfolio in Q1 2024.
  • Champlain Investment Partners opened 7 new positions and closed 6 in Q1 2024.
  • Champlain Investment Partners's portfolio value rose 3.5% quarter-over-quarter to $17.5B.

Based on Champlain Investment Partners's 13F filing for Q1 2024, filed 13 May 2024.